Research identifies lower risks for 42 different health outcomes in people taking these medications 1
A Clear Verdict Based On Current Evidence To date, there are no peer-reviewed human trials demonstrating that consumer GLP-1 patches activate GLP-1 receptors, support clinically meaningful appetite changes, or influence blood sugar through the same mechanisms as prescription medications
Microdosing Tirzepatide offers a more personalized approach with lower doses and steady clinical support
Four key questions on the new wave of anti-obesity drugs
Online Journal | Justin Plank | January 2025 Background Every year, the United States spends an estimated $173 billion treating obesity-related diseases like diabetes and heart disease, more than the annual budgets of 42 U.S
By slowing down the digestive process, reducing appetite, and regulating blood sugar levels, these medications offer a promising avenue for effective and holistic weight loss